Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
PLoS Med
    November 2017
  1. CASTILLO P, Hurtado JC, Martinez MJ, Jordao D, et al
    Validity of a minimally invasive autopsy for cause of death determination in maternal deaths in Mozambique: An observational study.
    PLoS Med. 2017;14:e1002431.
    >> Share

  2. MCNAIRY ML, Lamb MR, Gachuhi AB, Nuwagaba-Biribonwoha H, et al
    Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial.
    PLoS Med. 2017;14:e1002420.
    >> Share

  3. BOYD MA, Mocroft A, Ryom L, Monforte AD, et al
    Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
    PLoS Med. 2017;14:e1002424.
    >> Share

  4. HENRICH TJ, Hatano H, Bacon O, Hogan LE, et al
    HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
    PLoS Med. 2017;14:e1002417.
    >> Share

  5. KAPLAN SR, Oosthuizen C, Stinson K, Little F, et al
    Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
    PLoS Med. 2017;14:e1002407.
    >> Share

  6. EL-SADR WM, Harripersaud K, Rabkin M
    Reaching global HIV/AIDS goals: What got us here, won't get us there.
    PLoS Med. 2017;14:e1002421.
    >> Share

  7. POTEAT T, Ackerman B, Diouf D, Ceesay N, et al
    HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis.
    PLoS Med. 2017;14:e1002422.
    >> Share

  8. MAYER KH, Seaton KE, Huang Y, Grunenberg N, et al
    Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
    PLoS Med. 2017;14:e1002435.
    >> Share

  9. SZUBERT AJ, Prendergast AJ, Spyer MJ, Musiime V, et al
    Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    PLoS Med. 2017;14:e1002432.
    >> Share

  10. MORRIS L, Mkhize NN
    Prospects for passive immunity to prevent HIV infection.
    PLoS Med. 2017;14:e1002436.
    >> Share

  11. KATZ IT, Kaplan R, Fitzmaurice G, Leone D, et al
    Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    PLoS Med. 2017;14:e1002434.
    >> Share

  12. ELUL B, Lamb MR, Lahuerta M, Abacassamo F, et al
    A combination intervention strategy to improve linkage to and retention in HIV care following diagnosis in Mozambique: A cluster-randomized study.
    PLoS Med. 2017;14:e1002433.
    >> Share

    August 2017
  13. DE NEVE JW, Garrison-Desany H, Andrews KG, Sharara N, et al
    Harmonization of community health worker programs for HIV: A four-country qualitative study in Southern Africa.
    PLoS Med. 2017;14:e1002374.
    >> Share

  14. MYER L, Essajee S, Broyles LN, Watts DH, et al
    Pregnant and breastfeeding women: A priority population for HIV viral load monitoring.
    PLoS Med. 2017;14:e1002375.
    >> Share

    July 2017
  15. KARWA R, Maina M, Mercer T, Njuguna B, et al
    Leveraging peer-based support to facilitate HIV care in Kenya.
    PLoS Med. 2017;14:e1002355.
    >> Share

  16. ALIROL E, Wi TE, Bala M, Bazzo ML, et al
    Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.
    PLoS Med. 2017;14:e1002366.
    >> Share

  17. KOENIG SP, Dorvil N, Devieux JG, Hedt-Gauthier BL, et al
    Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial.
    PLoS Med. 2017;14:e1002357.
    >> Share

  18. SIMMS V, Dauya E, Dakshina S, Bandason T, et al
    Community burden of undiagnosed HIV infection among adolescents in Zimbabwe following primary healthcare-based provider-initiated HIV testing and counselling: A cross-sectional survey.
    PLoS Med. 2017;14:e1002360.
    >> Share

  19. GENG EH, Havlir DV
    The science of rapid start-From the when to the how of antiretroviral initiation.
    PLoS Med. 2017;14:e1002358.
    >> Share

  20. LIGHTFOOT M, Dunbar M, Weiser SD
    Reducing undiagnosed HIV infection among adolescents in sub-Saharan Africa: Provider-initiated and opt-out testing are not enough.
    PLoS Med. 2017;14:e1002361.
    >> Share

    June 2017
  21. MAHEU-GIROUX M, Vesga JF, Diabate S, Alary M, et al
    Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Cote d'Ivoire: Insights from mathematical modeling.
    PLoS Med. 2017;14:e1002321.
    >> Share

  22. TAYLOR M, Newman L, Ishikawa N, Laverty M, et al
    Elimination of mother-to-child transmission of HIV and Syphilis (EMTCT): Process, progress, and program integration.
    PLoS Med. 2017;14:e1002329.
    >> Share

    May 2017
  23. HAYES R, Floyd S, Schaap A, Shanaube K, et al
    A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    PLoS Med. 2017;14:e1002292.
    >> Share

  24. IWUJI C, Newell ML
    Towards control of the global HIV epidemic: Addressing the middle-90 challenge in the UNAIDS 90-90-90 target.
    PLoS Med. 2017;14:e1002293.
    >> Share

  25. BERNARD CL, Owens DK, Goldhaber-Fiebert JD, Brandeau ML, et al
    Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
    PLoS Med. 2017;14:e1002312.
    >> Share

    April 2017
  26. GRANICH R, Gupta S, Hall I, Aberle-Grasse J, et al
    Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review.
    PLoS Med. 2017;14:e1002253.
    >> Share

  27. FOX MP, Rosen S
    A new cascade of HIV care for the era of "treat all".
    PLoS Med. 2017;14:e1002268.
    >> Share

  28. SHARMA M, Barnabas RV, Celum C
    Community-based strategies to strengthen men's engagement in the HIV care cascade in sub-Saharan Africa.
    PLoS Med. 2017;14:e1002262.
    >> Share

  29. MCNAIRY ML, Abrams EJ, Rabkin M, El-Sadr WM, et al
    Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.
    PLoS Med. 2017;14:e1002278.
    >> Share

  30. GENG EH, Peiris D, Kruk ME
    Implementation science: Relevance in the real world without sacrificing rigor.
    PLoS Med. 2017;14:e1002288.
    >> Share

    February 2017
  31. MIKKELSEN E, Hontelez JA, Jansen MP, Barnighausen T, et al
    Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints.
    PLoS Med. 2017;14:e1002240.
    >> Share

  32. BEKKER LG, Gray GE
    Hope for HIV control in southern Africa: The continued quest for a vaccine.
    PLoS Med. 2017;14:e1002241.
    >> Share

    November 2016
  33. MASTERS SH, Agot K, Obonyo B, Napierala Mavedzenge S, et al
    Promoting Partner Testing and Couples Testing through Secondary Distribution of HIV Self-Tests: A Randomized Clinical Trial.
    PLoS Med. 2016;13:e1002166.
    >> Share

  34. FAIRALL LR, Folb N, Timmerman V, Lombard C, et al
    Educational Outreach with an Integrated Clinical Tool for Nurse-Led Non-communicable Chronic Disease Management in Primary Care in South Africa: A Pragmatic Cluster Randomised Controlled Trial.
    PLoS Med. 2016;13:e1002178.
    >> Share

  35. SHUBBER Z, Mills EJ, Nachega JB, Vreeman R, et al
    Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis.
    PLoS Med. 2016;13:e1002183.
    >> Share

    October 2016
  36. KUNKEL A, Cobelens FG, Cohen T
    Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis.
    PLoS Med. 2016;13:e1002142.
    >> Share

  37. BEYRER C, Makofane K, Orazulike I, Diouf D, et al
    Towards Equity in Service Provision for Gay Men and Other Men Who Have Sex with Men in Repressive Contexts.
    PLoS Med. 2016;13:e1002154.
    >> Share

    September 2016
  38. HORTON KC, MacPherson P, Houben RM, White RG, et al
    Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    PLoS Med. 2016;13:e1002119.
    >> Share

  39. MADANITSA M, Kalilani L, Mwapasa V, van Eijk AM, et al
    Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlle
    PLoS Med. 2016;13:e1002124.
    >> Share

  40. BORQUEZ A, Cori A, Pufall EL, Kasule J, et al
    The Incidence Patterns Model to Estimate the Distribution of New HIV Infections in Sub-Saharan Africa: Development and Validation of a Mathematical Model.
    PLoS Med. 2016;13:e1002121.
    >> Share

    Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now.
    PLoS Med. 2016;13:e1002133.
    >> Share

  42. MUGWANYA KK, Hendrix CW, Mugo NR, Marzinke M, et al
    Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
    PLoS Med. 2016;13:e1002132.
    >> Share

    August 2016
  43. ROSEN S, Fox MP, Larson BA, Sow PS, et al
    Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda.
    PLoS Med. 2016;13:e1002106.
    >> Share

  44. BINAGWAHO A, Kankindi I, Kayirangwa E, Nyemazi JP, et al
    Transitioning to Country Ownership of HIV Programs in Rwanda.
    PLoS Med. 2016;13:e1002075.
    >> Share

  45. IWUJI CC, Orne-Gliemann J, Larmarange J, Okesola N, et al
    Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.
    PLoS Med. 2016;13:e1002107.
    >> Share

  46. BAETEN JM, Heffron R, Kidoguchi L, Mugo NR, et al
    Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    PLoS Med. 2016;13:e1002099.
    >> Share

  47. KILMARX PH, Simbi R
    Progress and Challenges in Scaling Up Laboratory Monitoring of HIV Treatment.
    PLoS Med. 2016;13:e1002089.
    >> Share

  48. HABIYAMBERE V, Ford N, Low-Beer D, Nkengasong J, et al
    Availability and Use of HIV Monitoring and Early Infant Diagnosis Technologies in WHO Member States in 2011-2013: Analysis of Annual Surveys at the Facility Level.
    PLoS Med. 2016;13:e1002088.
    >> Share

  49. JAY J, Buse K, Hart M, Wilson D, et al
    Building from the HIV Response toward Universal Health Coverage.
    PLoS Med. 2016;13:e1002083.
    >> Share

    June 2016
  50. ROSEN S, Maskew M, Fox MP, Nyoni C, et al
    Correction: Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    PLoS Med. 2016;13:e1002050.
    >> Share

  51. ROCHAT TJ, Houle B, Stein A, Coovadia H, et al
    Exclusive Breastfeeding and Cognition, Executive Function, and Behavioural Disorders in Primary School-Aged Children in Rural South Africa: A Cohort Analysis.
    PLoS Med. 2016;13:e1002044.
    >> Share

    May 2016
  52. ROSEN S, Maskew M, Fox MP, Nyoni C, et al
    Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    PLoS Med. 2016;13:e1002015.
    >> Share

  53. MARSEILLE E, Kahn JG
    A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact.
    PLoS Med. 2016;13:e1002031.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016